[1]
Q. Kong, “Analysis of Current Situation and Countermeasures of Drug Supply Chain of Centralized Procurement in China”, FBEM, vol. 13, no. 3, pp. 363–365, Mar. 2024, doi: 10.54097/rhrzdx16.